Stock & Company Details
Compass Therapeutics Inc $CMPX
Price:
N/A
N/A
180M
$137M
52 Week High:
N/A
10 Day Average Volume:
N/A
-2.41
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
CMPX technical indicators
Latest Compass Therapeutics Inc (CMPX) indicator readings as of 2026-10-29.
CMPX's 14-day RSI is 22.5, in oversold territory. At $0.76 it is trading 76.5% below its 200-day moving average of $3.22, and below its 50-day average of $1.49. Price sits near the lower Bollinger Band ($0.69 to $1.04). ADX reads 58.3, indicating a trending market.
Overview
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. The company has drugged over 40 immune targets and generated a diverse pipeline of monoclonal and multispecific therapeutic candidates with potential to transform care for patients with cancer or autoimmune diseases.
Finance Bot
Ask your questions
Start by typing a question below.
